Full Spectrum of Production Capabilities Designed for Customers Experiencing Rapid Growth in the Commercialization of new Microfluidic-based Diagnostics
Somersworth, NH (August 1, 2016) – J-Pac Medical, a trusted manufacturing and packaging outsourcing partner for medical device and diagnostic companies seeking to deliver superior quality, improve time-to-market and simplify their supply chain, today announced that it will now offer new high-volume automated manufacturing capabilities specifically designed for the company’s on-chip reagent blister technology.
J-Pac Medical’s full spectrum of automated production capabilities is designed for customers experiencing rapid growth in the commercialization of new microfluidic-based diagnostics — from prototyping, pilot production, clinical trials, product launch and full commercialization. As the market leader for reagent blisters, J-Pac can now manufacture tens of millions reagent blisters to support customers from concept through global commercialization.
“J-Pac Medical’s expertise in medical grade polymer manipulation, frangible and burst seal technology, and ongoing investments in unit-of-use reagent reservoirs and unit dose delivery systems that integrate into various stat testing applications have made the company a trusted partner for developing microfluidic-based diagnostic products,” said Jeff Barrett, president and CEO, J-Pac Medical. “We are proud to be a partner our customers can count on from concept to full scale commercialization. These new high- volume manufacturing capabilities will enable us to further support our customers’ needs throughout the entire life cycle as they experience continued success in this market.”
J-Pac Medical’s unique high-volume, automated production capabilities have been developed to incorporate the highest precision for unit dose reagent blisters. This includes:
- Precision reagent filling for single and multiple-well formats with in-line quality control
- Self-diagnostics with automated detection of non-conforming materials
- Multiple sealing profiles unique to each customer application
Microfluidic diagnostic platforms utilizing J-Pac Medical’s on-chip reagent blisters help eliminate multi-step lab processes where human error and instrument contamination are most likely to occur. J-Pac has developed two reagent delivery technologies in single or multi-well formats for common lab-on-chip formats: burst and frangible seal blisters. Frangible and burst seal technology reduces test complexity by storing and enabling the controlled release of testing reagents, eliminating the need for complex fluid handling. As a result, the device manufacturer is able to better control performance variability, reduce overall manufacturing and disposal costs, and simplify the end-user experience.
J-Pac will be exhibiting in Booth 4272 at the 68th AACC Annual Scientific Meeting & Clinical Lab Expo taking place July 31st – August 4th in Philadelphia, PA.
About J-Pac Medical
J-Pac Medical is a trusted manufacturing and packaging outsourcing partner to medical device and diagnostic companies seeking to deliver superior quality, improve time-to-market and simplify the supply chain for single-use medical devices. With more than 30 years of experience in complex thermoplastic devices and packaging, J-Pac Medical has the unique technology that allows it to manufacture anatomically correct, class III implantable textile assemblies, lab-on-chip reagent blisters, and complex thermoformed packaging. Additionally, the company offers full-service supply chain management, packaging and sterilization.
The largest medical device companies in the world rely on J-Pac Medical to help meet the most difficult development, manufacturing, and logistics and supply chain challenges. For more information, visit www.j-pacmedical.com.
J-Pac Medical is FDA Registered (#1221051) as a Medical Device Manufacturer and a Device Labeller/Relabeller; and Certified to ISO 13485 standards through BSI.
# # #
For more information contact:
SVM Public Relations